Visualitzant VHIO - Articles científics per títol
Ara mostrant els elements 41-60 d 864
-
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology
(SAGE Publications, 2023) -
A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?
(Nature Portfolio, 2024-02-21) -
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
(American Society of Clinical Oncology, 2020-12-01) -
Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation
(Nature Research, 2021-02-23) -
Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - an update on neuroendocrine neoplasm's treatment: A case report
(Baishideng Publishing Group, 2021-05-27) -
Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials
(Nature Research, 2022-05-24) -
Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial
(Wolters Kluwer Health, 2021-08) -
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
(American Society of Clinical Oncology, 2023-04-10) -
Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors
(Elsevier, 2021-02) -
Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer
(Frontiers Media, 2023-02-02) -
Advances in immunotherapy for cervical cancer
(SAGE Publications, 2023-03-28) -
Advances in the systemic treatment of therapeutic approaches in biliary tract cancer
(Elsevier, 2022-06)